Hansoh Pharmaceutical Group Co., Ltd. Logo

Hansoh Pharmaceutical Group Co., Ltd. (3KY)

FSX

Currency in EUR
3.70
+0.02 (+0.49%)

Real-time Data

06:00 AM

Day's Range

3.68
3.70

52 wk Range

3.09
4.80

Overview - 3KY - Hansoh Pharmaceutical Group Co., Ltd.

Key Statistics

Valuation

Enterprise Value

-1.49B

P/E (Trailing)

‪29.52‬

Price / Sales (TTM)

‪1.35‬

Price / Book

‪4.43‬

EV / EBITDA

‪-1.85‬

Profitability

Profit Margin

‪42.00%‬

Operating Margin

‪44.37%‬

Return on Assets

‪9.08%‬

Return on Equity

‪19.39%‬

Ownership

Shares Outstanding

6.05B

Float

1.23B

Held by Insiders

‪79.55%‬

Held by Institutions

‪12.28%‬

Price stats

Beta

‪0.56‬

50-Day Avg

‪3.63‬

200-Day Avg

‪3.81‬

Dividends

Payout Ratio

‪36.07%‬

Frequency

Semi-Annual

News Teaser - 3KY - Hansoh Pharmaceutical Group Co., Ltd.

News & Analysis

View all news

Market Cap - 3KY - Hansoh Pharmaceutical Group Co., Ltd.

Peers - 3KY - Hansoh Pharmaceutical Group Co., Ltd.

Peer Comparison

Compared with companies in Drug Manufacturers - Specialty & Generic listed on FSX.

Profile Summary - 3KY - Hansoh Pharmaceutical Group Co., Ltd.

About

Hansoh Pharmaceutical Group Co., Ltd. is a leading biopharmaceutical company that primarily specializes in the research, development, manufacturing, and sale of innovative therapeutics. The company focuses on addressing unmet medical needs in areas such as oncology, central nervous system disorders, anti-diabetes, and…

SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
Employees9.34K
Full company profile

The information on this page is provided for general informational purposes only and is not investment advice.

Market data provided by Twelve Data. Charting by TradingView.

Last updated:

Track Global Markets in Real Time with UA Finance

Download the app now and access live financial data, expert analysis, and trusted economic news to follow stocks, forex, gold, and cryptocurrencies with ease.